loder

Global Neurorehabilitation Devices Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report

Neurorehabilitation Devices Market - By Product: Robotic Systems, BCIs; By End User: Hospitals, Home Care; By Region: North America, Europe, Asia-Pacific Latin America and Others

Report Code
CVMI2501165
Published
March 3, 2025
Last Updated
March 3, 2025
Coverage
Healthcare • Medical Devices
Analyst-led, consultative delivery
Enterprise-ready licensing options
Fast turnarounds for custom cuts

Market Snapshot

High-signal KPIs designed for executive scanning.
Indicative snapshot. Request sample for full model outputs.
Market Size (latest)
vs. prior year
CAGR
Forecast window:
Forecast Period
2024–2031
Base years: 2019–2023
Coverage Depth
Segments • Regions • Players

Insights

Consultative narrative + actionable decision support.

Market Overview:

The neurorehabilitation devices market encompasses robotic exoskeletons, brain-computer interfaces (BCIs), non-invasive stimulators, and virtual reality (VR) systems designed to restore motor and cognitive function in patients with stroke, spinal cord injuries, Parkinson’s disease, and multiple sclerosis. This market is driven by the increasing prevalence of neurological disorders, aging populations, and technological advancements, moving towards home-based, AI-driven rehabilitation.

 

Market Size and Forecast

Year

Market Value (USD Billion)

Notes

2023

2.1

Dominated by robotic gait trainers (45% share).

2028

5.8

CAGR 22.5% (2023–2028); VR/BCI adoption soars.

2035

14.3

CAGR 18.7% (2028–2035); home-use devices claim 40% share.

1.2 million+ devices in use by 2035, with 60% deployed in post-stroke rehab.

 

Market Drivers

  • Neurological Epidemic: Stroke Cases Set to Rise by 34% Globally (2023–2035).
  • Home healthcare trend: 50% of patients prefer telerehabilitation post-COVID.
  • AI/ML integration: Devices like Rewalk Robotics’ exoskeletons adapt to patient progress in real-time.
  • Government funding: NIH allocates USD 500M/year for neurotech R&D.

 

Market Challenges

  • High costs: Exoskeletons typically average between USD 70,000 and 150,000.
  • Reimbursement gaps: Only 25% of insurers cover home-based neuro rehab.
  • Clinical validation: BCIs require 5–7 years of trials for FDA approval.

Competitive Landscape

Company

2023 Share

Core Strengths

Recent Moves

Hocoma (DKSH)

30%

Robotic gait trainers

Launched AI-powered Lokomat (2024).

Ekso Bionics

20%

Exoskeletons for stroke

Won USD 40M DoD contract (2025).

Neuroelectrics

15%

Non-invasive tDCS/tACS

FDA-cleared Starstim for home use (2025).

Startups (e.g., MindMaze)

35%

VR neurorehab

Raised USD 200M for PTSD therapy (2024).

 

Market Segmentation

Segment

2023 Share

CAGR (2023–2035)

By Product

   

Robotic Systems

45%

20.1%

BCIs

15%

28.5%

By End User

   

Hospitals

50%

17.8%

Home Care

30%

25.4%

 

Regional Analysis

  • North America (XX%): The U.S. leads with Medicare coverage for robotic rehabilitation.
  • Europe (35%): Germany’s universal healthcare drives adoption.
  • Asia-Pacific (XX%): Japan invests in stroke rehab centers.

Technology & Innovation

  • Hybrid exoskeletons: Combine robotics + functional electrical stimulation (FES).
  • Cloud-based rehab: Therapists monitor patients remotely via AI dashboards.
  • Gamified VR: MindMaze’s VR games improve compliance in pediatric rehab.

 

Regulatory Environment

  • FDA: Expedited pathway for breakthrough neurodevices.
  • EU MDR: Class III certification required for invasive BCIs.

 

Strategic Outlook

  • Providers: Partner with insurers to expand reimbursement.
  • OEMs: Focus on modular, affordable home devices.
Unlock the executive summary.
Request the sample to review key questions answered.
See what’s included.
Request sample for scope, definitions and segmentation.

Key Players

  • Hocoma AG
  • Bionik Laboratories Corp.  
  • Abbott Laboratories
  • Ectron Ltd.
  • Ekso Bionics Holdings, Inc.  
  • Medtronic plc
  • Bioventus LLC
  • Bioness Inc.
  • BioXtreme Robotics Rehabilitation
  • Neuro Rehab VR  
  • Tyromotion GmbH
  • Kinova Inc.
  • Saebo, Inc.
  • ReWalk Robotics Ltd.  
  • Helius Medical Technologies
Competitive Dashboard Preview
Shortlist strategic accounts and benchmark positioning.
Loading…
Request Competitive Cut

Segmentation Explorer

Interactively explore markets by segment and geography.
Refine View
Opportunity Index
Directional signals for prioritization and scenario framing.
Interactive
Need a board-ready slide? .
Modeling inputs: analyst assumptions, secondary sources, triangulated validations.

Table Of Contents

Expandable preview of coverage and chapter structure.

Neurorehabilitation Devices Market Report



  1. 1. Neurorehabilitation Devices Market Research Report
    1. 1.1 Study Objectives
    2. 1.2 Neurorehabilitation Devices Market - Overview
    3. 1.3 Reason to Read This Report
    4. 1.4 Methodology and Forecast Analysis
  2. 2. Neurorehabilitation Devices Market Research Report - Preface
    1. 2.1 Neurorehabilitation Devices Market Research Report – Detailed Scope and Definitions
      1. 2.1.1 By Product
      2. 2.1.2 By End User
      3. 2.1.3 By Region
  3. 3. Neurorehabilitation Devices Market Dynamics
    1. 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
    2. 3.2. Restraints – By Product, By End User, By Country
    3. 3.3. Opportunities – By Product, By End User, By Country
    4. 3.4. Trends – By Product, By End User, By Country
    5. 3.5. PEST Analysis
    6. 3.6. Porters Five Rule Analysis
    7. 3.7. Company’s Share Analysis (CSA) by Region or By Country
    8. 3.8. Neurorehabilitation Devices Market Research Report – DROTs Impact Analysis
    1. 4. Neurorehabilitation Devices Market Research Report, Historic Data 2019 - 2023 and Forecast Analysis Data 2024 - 2031
    2. 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    3. 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
    4. 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
    5. 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
  1. 5. Neurorehabilitation Devices Market, By Product, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 5.1 Robotic Systems
    2. 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    3. 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    4. 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    5. 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. 5.2 BCIs
    7. 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    8. 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    9. 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    10. 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. Neurorehabilitation Devices Market, By End User, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 6.1 Hospitals
    2. 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    3. 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    4. 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    5. 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. 6.2 Home Care
    7. 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    8. 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    9. 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    10. 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
  1. 7. Neurorehabilitation Devices Market Forecast, By Region, 2019 - 2023 and 2024 - 2031 (Market Value, In USD Mn)
    1. 7.1 North America
      1. 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
      7.2 Europe
      1. 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
      7.3 Asia-Pacific
      1. 7.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
      7.4 Latin America
      1. 7.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
      7.5 Middle East and Africa
      1. 7.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
      7.6 Neurorehabilitation Devices Market - Opportunity Analysis Index, By Product, By End User, and Region, 2024 - 2031
  1. 8. North America Neurorehabilitation Devices Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 8.1 By Product Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 8.1.1 Robotic Systems
      2. 8.1.2 BCIs
      8.2 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 8.2.1 Hospitals
      2. 8.2.2 Home Care
      8.3 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 8.3.1 United States
      2. 8.3.2 Canada
    2. 8.4 North America Neurorehabilitation Devices Market – Opportunity Analysis Index, By Product, By End User, and Country, 2024 - 2031
    3. 8.5 Regional Trends Analysis
    4. 8.6 North America Neurorehabilitation Devices Market Research Report - Company Profiles
      1. 8.6.1 Company 1 (United States)
      2. 8.6.2 Company 2 (Canada)
      3. 8.6.3 Company 3 (Canada)
    9. Europe Neurorehabilitation Devices Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 9.1 By Product Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.1.1 Robotic Systems
      2. 9.1.2 BCIs
      9.2 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.2.1 Hospitals
      2. 9.2.2 Home Care
      9.3 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.3.1 Germany
      2. 9.3.2 United Kingdom
      3. 9.3.3 France
      4. 9.3.4 Spain
      5. 9.3.5 Italy
      6. 9.3.6 Russia
    2. 9.4 Europe Neurorehabilitation Devices Market – Opportunity Analysis Index, By Product, By End User, and Country, 2024 - 2031
    3. 9.5 Regional Trends Analysis
    4. 9.6 Europe Neurorehabilitation Devices Market Research Report - Company Profiles
      1. 9.6.1 Company 1 (Germany)
      2. 9.6.2 Company 2 (United Kingdom)
      3. 9.6.3 Company 3 (United Kingdom)
    10. Asia-Pacific Neurorehabilitation Devices Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 10.1 By Product Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.1.1 Robotic Systems
      2. 10.1.2 BCIs
      10.2 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.2.1 Hospitals
      2. 10.2.2 Home Care
      10.3 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.3.1 China
      2. 10.3.2 Japan
      3. 10.3.3 India
      4. 10.3.4 South Korea
      5. 10.3.5 Australia & New Zealand
      6. 10.3.6 ASEAN
    2. 10.4 Asia-Pacific Neurorehabilitation Devices Market – Opportunity Analysis Index, By Product, By End User, and Country, 2024 - 2031
    3. 10.5 Regional Trends Analysis
    4. 10.6 Asia-Pacific Neurorehabilitation Devices Market Research Report - Company Profiles
      1. 10.6.1 Company 1 (China)
      2. 10.6.2 Company 2 (Japan)
      3. 10.6.3 Company 3 (Japan)
    11. Latin America Neurorehabilitation Devices Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 11.1 By Product Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.1.1 Robotic Systems
      2. 11.1.2 BCIs
      11.2 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.2.1 Hospitals
      2. 11.2.2 Home Care
      11.3 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.3.1 Brazil
      2. 11.3.2 Mexico
      3. 11.3.3 Argentina
      4. 11.3.4 Peru
      5. 11.3.5 Colombia
      6. 11.3.6 Rest of Latin America
    2. 11.4 Latin America Neurorehabilitation Devices Market – Opportunity Analysis Index, By Product, By End User, and Country, 2024 - 2031
    3. 11.5 Regional Trends Analysis
    4. 11.6 Latin America Neurorehabilitation Devices Market Research Report - Company Profiles
      1. 11.6.1 Company 1 (Brazil)
      2. 11.6.2 Company 2 (Mexico)
      3. 11.6.3 Company 3 (Mexico)
    12. Middle East and Africa Neurorehabilitation Devices Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 12.1 By Product Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.1.1 Robotic Systems
      2. 12.1.2 BCIs
      12.2 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.2.1 Hospitals
      2. 12.2.2 Home Care
      12.3 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.3.1 Saudi Arabia
      2. 12.3.2 UAE
      3. 12.3.3 South Africa
      4. 12.3.4 Egypt
      5. 12.3.5 Israel
      6. 12.3.6 Rest of Middle East and Africa
    2. 12.4 Middle East and Africa Neurorehabilitation Devices Market – Opportunity Analysis Index, By Product, By End User, and Country, 2024 - 2031
    3. 12.5 Regional Trends Analysis
    4. 12.6 Middle East and Africa Neurorehabilitation Devices Market Research Report - Company Profiles
      1. 12.6.1 Company 1 (Saudi Arabia)
      2. 12.6.2 Company 2 (UAE)
      3. 12.6.3 Company 3 (UAE)
    13. Competition Landscape
    1. 13.1 Strategic Dashboard of Top Market Players
    2. 13.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)
      1. 13.2.1 Hocoma AG
      2. 13.2.2 Bionik Laboratories Corp.
      3. 13.2.3 Abbott Laboratories
      4. 13.2.4 Ectron Ltd.
      5. 13.2.5 Ekso Bionics Holdings Inc.
      6. 13.2.6 Medtronic plc
      7. 13.2.7 Bioventus LLC
      8. 13.2.8 Bioness Inc.
      9. 13.2.9 BioXtreme Robotics Rehabilitation
      10. 13.2.10 Neuro Rehab VR
      11. 13.2.11 Tyromotion GmbH
      12. 13.2.12 Kinova Inc.
      13. 13.2.13 Saebo Inc.
      14. 13.2.14 ReWalk Robotics Ltd.
      15. 13.2.15 Helius Medical Technologies.
  1. 14. Data Collection Method and Research Approach
  2. 15. Principal Presumptions and Acronyms

Methodology & Credibility

Built for enterprise decisions, not vanity metrics.
Triangulated Sizing
Bottom-up, top-down, and peer benchmarks reconciled by analysts.
Primary + Secondary Research
Executive interviews combined with validated public and paid sources.
Scenario & Sensitivity
Base, bull and bear cases to stress-test strategic moves.
Need Confidence Fast?
We’ll map your questions to the report in 15 minutes.
Book A Consultation
Preferred by strategy, marketing, and corporate development teams.

Related Reports

More coverage in adjacent themes and segments.
Ready to move from data to decision?
Get the report, request a sample, or book a consultative briefing.
New chat message received
×

Need help?

Chat with our team in a minute.